Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. CYCN.NASDAQ

Cyclerion Therapeutics Inc (CYCN NASDAQ) stock market data APIs

$3.31 0.19(6.1%) as of July 26, 2024
Price chart is built with Anychart

Cyclerion Therapeutics, Inc., a biopharmaceutical company, develops treatments for serious diseases. It is developing Olinciguat, an orally administered vascular soluble guanylate cyclase (sGC) stimulator, which is in Phase 2 clinical trial to out-license for cardiovascular diseases; and Praliciguat, a systemic sGC stimulator that is licensed to Akebia Therapeutics, Inc. for the treatment of rare kidney disease. The company was incorporated in 2018 and is headquartered in Cambridge, Massachusetts.

Cyclerion Therapeutics Inc Financial Data Overview

3.12
3.31
-
3.61
2.99
1.7501-5.25
8 224 K
2 500 K
1 328 K
1.916
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'CYCN',
Type: 'Common Stock',
Name: 'Cyclerion Therapeutics Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00KXXHYD9',
ISIN: NULL,
CUSIP: NULL,
CIK: '1755237',
EmployerIdNumber: '83-1895370',
FiscalYearEnd: 'December',
IPODate: '2019-04-02',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,
}

Cyclerion Therapeutics Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 1 328 K
  • EBITDA -9 582 000
  • Earnings Per Share -4.55
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Cyclerion Therapeutics Inc Earnings via APIs

  • Latest Release 2024-07-26
  • EPS/Forecast NaN

Get Cyclerion Therapeutics Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Cyclerion Therapeutics Inc latest news via APIs

12 Best Biotech Penny Stocks to Invest In

In this article, we discuss the 12 best biotech penny stocks to invest in. If you want to skip our detailed analysis of these stocks, go directly to 5 Best Biotech Penny Stocks to Invest In. The past...

The Petri Dish: Alexion buys Pfizer gene therapies in $1B deal; Peter Hecht's plan to save Cyclerion assets

Peter Hecht, the co-founder and CEO of embattled biotech Cyclerion Therapeutics Inc. (Nasdaq: CYCN), is heading up a new startup that's effectively a life raft for Cyclerion's research. Elsewhere in t...
Do you have any questions?
support@eodhistoricaldata.com